182 related articles for article (PubMed ID: 11274927)
41. Vascular adhesion protein-1 enhances neutrophil infiltration by generation of hydrogen peroxide in renal ischemia/reperfusion injury.
Tanaka S; Tanaka T; Kawakami T; Takano H; Sugahara M; Saito H; Higashijima Y; Yamaguchi J; Inagi R; Nangaku M
Kidney Int; 2017 Jul; 92(1):154-164. PubMed ID: 28318627
[TBL] [Abstract][Full Text] [Related]
42. Pharmacologic blockade of vascular adhesion protein-1 lessens neurologic dysfunction in rats subjected to subarachnoid hemorrhage.
Xu HL; Garcia M; Testai F; Vetri F; Barabanova A; Pelligrino DA; Paisansathan C
Brain Res; 2014 Oct; 1586():83-9. PubMed ID: 25175836
[TBL] [Abstract][Full Text] [Related]
43. A novel endothelial cell molecule mediating lymphocyte binding in humans.
Jalkanen S; Salmi M
Behring Inst Mitt; 1993 Aug; (92):36-43. PubMed ID: 8250815
[TBL] [Abstract][Full Text] [Related]
44. Enzymatic control of leukocyte trafficking: role of VAP-1.
Salmi M; Jalkane S
Adv Exp Med Biol; 2002; 512():57-63. PubMed ID: 12405188
[No Abstract] [Full Text] [Related]
45. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
46. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
[TBL] [Abstract][Full Text] [Related]
47. Adhesion molecules in CNS disorders: biomarker and therapeutic targets.
Ma Q; Chen S; Klebe D; Zhang JH; Tang J
CNS Neurol Disord Drug Targets; 2013 May; 12(3):392-404. PubMed ID: 23469854
[TBL] [Abstract][Full Text] [Related]
48. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
49. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.
Elo P; Tadayon S; Liljenbäck H; Teuho J; Käkelä M; Koskensalo K; Saunavaara V; Virta J; Veres TZ; Kiviniemi A; Saraste A; Marjamäki P; Airas L; Jalkanen S; Roivainen A
J Neuroinflammation; 2018 May; 15(1):128. PubMed ID: 29716612
[TBL] [Abstract][Full Text] [Related]
50. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
51. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
[TBL] [Abstract][Full Text] [Related]
52. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion.
Salmi M; Rajala P; Jalkanen S
J Clin Invest; 1997 May; 99(9):2165-72. PubMed ID: 9151788
[TBL] [Abstract][Full Text] [Related]
53. Human vascular adhesion protein-1 in smooth muscle cells.
Jaakkola K; Kaunismäki K; Tohka S; Yegutkin G; Vänttinen E; Havia T; Pelliniemi LJ; Virolainen M; Jalkanen S; Salmi M
Am J Pathol; 1999 Dec; 155(6):1953-65. PubMed ID: 10595925
[TBL] [Abstract][Full Text] [Related]
54. Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo.
Marttila-Ichihara F; Smith DJ; Stolen C; Yegutkin GG; Elima K; Mercier N; Kiviranta R; Pihlavisto M; Alaranta S; Pentikäinen U; Pentikäinen O; Fülöp F; Jalkanen S; Salmi M
Arthritis Rheum; 2006 Sep; 54(9):2852-62. PubMed ID: 16947396
[TBL] [Abstract][Full Text] [Related]
55. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse.
Merinen M; Irjala H; Salmi M; Jaakkola I; Hänninen A; Jalkanen S
Am J Pathol; 2005 Mar; 166(3):793-800. PubMed ID: 15743791
[TBL] [Abstract][Full Text] [Related]
56. L-lysine as a recognition molecule for the VAP-1 function of SSAO.
Olivieri A; Tipton K; O'Sullivan J
J Neural Transm (Vienna); 2007; 114(6):747-9. PubMed ID: 17393063
[TBL] [Abstract][Full Text] [Related]
57. Cell surface monoamine oxidases: enzymes in search of a function.
Jalkanen S; Salmi M
EMBO J; 2001 Aug; 20(15):3893-901. PubMed ID: 11483492
[TBL] [Abstract][Full Text] [Related]
58. Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.
Martelius T; Salmi M; Wu H; Bruggeman C; Höckerstedt K; Jalkanen S; Lautenschlager I
Am J Pathol; 2000 Oct; 157(4):1229-37. PubMed ID: 11021827
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
[TBL] [Abstract][Full Text] [Related]
60. Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors.
Kiss J; Jalkanen S; Fülöp F; Savunen T; Salmi M
Eur J Immunol; 2008 Nov; 38(11):3041-9. PubMed ID: 18991279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
